March 23, 2018 / 6:17 AM / in a month

BRIEF-Novo Nordisk Says Ozempic Approved In Japan For The Treatment Of Type 2 Diabetes

Reuters Staff

1 Min Read

March 23 (Reuters) - NOVO NORDISK A/S SAYS:

* OZEMPIC APPROVED IN JAPAN FOR THE TREATMENT OF TYPE 2 DIABETES

* EXPECTS TO LAUNCH OZEMPIC® IN JAPAN IN THE COMING MONTHS, WHEN REIMBURSEMENT HAS BEEN OBTAINED. SOURCE TEXT FOR EIKON: FURTHER COMPANY COVERAGE: (Reporting by Jacob Gronholt-Pedersen)

Our Standards:The Thomson Reuters Trust Principles.

0 : 0

narrow-browser-and-phone
medium-browser-and-portrait-tablet
landscape-tablet
medium-wide-browser
wide-browser-and-larger
medium-browser-and-landscape-tablet
medium-wide-browser-and-larger
above-phone
portrait-tablet-and-above
above-portrait-tablet
landscape-tablet-and-above
landscape-tablet-and-medium-wide-browser
portrait-tablet-and-below
landscape-tablet-and-below

All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.